N
Naoya Murakami
Researcher at University of Tokyo
Publications - 162
Citations - 1852
Naoya Murakami is an academic researcher from University of Tokyo. The author has contributed to research in topics: Brachytherapy & Radiation therapy. The author has an hindex of 20, co-authored 121 publications receiving 1305 citations. Previous affiliations of Naoya Murakami include Technische Universität München.
Papers
More filters
Journal ArticleDOI
The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma
E. Rand Simpson,Brenda L. Gallie,Normand Laperrierre,Akbar Beiki-Ardakani,Tero Kivelä,Virpi Raivio,Jorma Heikkonen,Laurence Desjardins,Rémi Dendale,A. Mazal,Norbert Bornfeld,Wolfgang Sauerwein,D. Fluehs,Lorenzo Brualla,Santosh G Honavar,Vijay Anand P. Reddy,Shigenobu Suzuki,Naoya Murakami,S.V. Saakyan,Vladimir Valskiy,Anush Amiryan,Stefan Seregard,Charlotta All-Eriksson,Lars Hjelmqvist,Göran Lundell,Georges Sinclair,Marie Lundell,Bertil Damato,R Doug Errington,P. Mayles,Helen Mayles,Chris S. Bergstrom,Hans E. Grossniklaus,Ian R. Crocker,Elizabeth Butker,Matthew W. Wilson,Barrett G. Haik,Holger Geischen,Pradeep Patra,Jay S. Duker,John E. Mignano,Mark J. Rivard,Paul T. Finger,Ekaterina Semenova,Walter Choi,Nina Kalach +45 more
TL;DR: The American Brachytherapy Society (ABS) as mentioned in this paper developed a set of guidelines for plaque brachythermytherapy of choroidal melanoma and retinoblastoma.
Journal ArticleDOI
Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma.
Hideomi Yamashita,Hiroshi Onishi,Naoya Murakami,Yasuo Matsumoto,Yukinori Matsuo,Takuma Nomiya,Keiichi Nakagawa +6 more
TL;DR: PFS after SBRT for liver tumor was satisfactory, especially for Stage I HCC, even though these patients were unsuitable for resection and ablation, and SBRt is safe and might be an alternative to resectionand ablation.
Journal ArticleDOI
Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
Ken Harada,Naoya Murakami,Mayuka Kitaguchi,Shuhei Sekii,Kana Takahashi,Kotaro Yoshio,Koji Inaba,Madoka Morota,Yoshinori Ito,Minako Sumi,Shigenobu Suzuki,Kensei Tobinai,Takashi Uno,Jun Itami +13 more
TL;DR: The majority of patients with POAML showed behavior consistent with that of localized, indolent diseases, and Thirty gray of local irradiation seems to be quite effective.
Journal ArticleDOI
Role of membrane Hsp70 in radiation sensitivity of tumor cells
Naoya Murakami,Annett Kühnel,Thomas E. Schmid,K. Ilicic,Stefan Stangl,Isabella S. Braun,Mathias Gehrmann,Michael Molls,Jun Itami,Gabriele Multhoff +9 more
TL;DR: The results indicate that mHsp70 has an impact on radiation resistance in tumor sublines that differ in their cytosolic and/or mHSP70 levels.
Journal ArticleDOI
CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer
Naoya Murakami,Takahiro Kasamatsu,Akihisa Wakita,Satoshi Nakamura,Hiroyoki Okamoto,Koji Inaba,Madoka Morota,Yoshinori Ito,Minako Sumi,Jun Itami +9 more
TL;DR: Volume-dose showed a relationship to the clinical outcome in CT based brachytherapy for cervical carcinoma and correlation between clinical outcome and dose of HR-CTV was analyzed.